FDA-Inspected Site

Daito Pharmaceutical Co., Ltd

8 FDA inspections are on record for Daito Pharmaceutical Co., Ltd in Toyama, Japan.

483· Form 483 issued

Toyama, Japan · Last updated July 9, 2026

Overview

  • 8 FDA inspections are on record.
  • 7 inspections produced a Form 483.
  • The most recent recorded inspection date is 2023-12-19.

At a glance

Inspections

8

Form 483s

7

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
11 Dec 2023 – 19 Dec 2023Human Drugs483View 483 →
12 Sep 2022 – 16 Sep 2022Human Drugs483On file
27 Jan 2020 – 31 Jan 2020Human Drugs483On file
6 Nov 2017 – 10 Nov 2017Human Drugs483On file
7 Oct 2013 – 10 Oct 2013Human Drugs483On file
29 Sep 2011Not recorded483On file
25 Feb 2008Not recorded483On file
20 Apr 2006Not recordedClean

Observations on record

Form 483 observations cited at this site, most recent first.

19 Dec 2023
21 CFR 211.160(b)

Scientifically sound laboratory controls

Cited by Truong X Nguyen

19 Dec 2023
21 CFR 211.67(b)

Written procedures not established/followed

Cited by Truong X Nguyen

Investigators

FDA investigators tied to this site in the record.

Azza Talaat1 insp.
Katherine Szestypalow1 insp.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.160(b)Cited across public-safe Form 483 observations1x
21 CFR 211.67(b)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Daito Pharmaceutical Co., Ltd's 7 Form 483s

Source PDFs and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat